Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Ventricular Tachycardia, Ventricular FibrillationHeart Failure
Interventions
DEVICE

Cognis 100-D, Teligen DR, VR 100 HE

ICD or CRT - Therapy

Trial Locations (4)

2900

KAS Gentofte Hospital, Hellerup

52621

Sheba Medical Center, Tel Litwinsky

64239

Tel Aviv Medical Center, Tel Aviv

78306

Barzilay Medical Center, Ashkelon

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Guidant Corporation

INDUSTRY

NCT00606710 - Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following | Biotech Hunter | Biotech Hunter